ArticleAnnals of translational medicine2019

Preclinical safety evaluation of chimeric antigen receptor-modified T cells against CD19 in NSG mice.

Hairuo Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.